Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?
Open Access
- 15 September 2000
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 106 (6) , 733-738
- https://doi.org/10.1172/jci11144
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertensionThe FASEB Journal, 2001
- Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1Journal of Clinical Investigation, 2000
- Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscleJournal of Clinical Investigation, 2000
- Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter geneJournal of Clinical Investigation, 2000
- Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertensionJournal of Clinical Investigation, 1999
- The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxiaJournal of Clinical Investigation, 1999
- Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.Journal of Clinical Investigation, 1998
- Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1αGenes & Development, 1998
- Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.Journal of Clinical Investigation, 1996
- The Terminal Portion of the Pulmonary Arterial Tree in People Native to High AltitudesCirculation, 1963